This review examines the epidemiology, transmission, clinical presentation, assessment and diagnosis, prognosis, management and treatment, and prevention
Pustular psoriasis, pemphigus foliaceus and impetigo have been discussed. An association with gammapathies has been reported. Treatment with dapsone has proved useful but recurrences occur. Sulfapyridine does not exist anymore in France and some authors have suggested acitretin to treat recurrences....
AbstractforPrevalence and Socio-Demographic and Hygiene Factors Influencing Impetigo in Saudi Arabian Children: A Cross-Sectional Investigation | Full Text | References | PDF (1.2 MB) | EPUB 146 Views 0 CrossRef citations 0Altmetric Open Access Article A Mixture of Water-Soluble Polysaccharides Reduc...
She also experienced an impetigo-like infectious cutaneous lesion due to Staphylococcus aureus infection. She received standard childhood vaccinations without any complications. Upon physical examination, the liver and spleen were palpable, 3 cm and 2 cm below the edge of the ribs, respectively. ...
Seborrheic Dermatitis, Psoriasis and Impetigo in Children Clinical Presentation General features[2,4,6] Pruritic, erythematous papules and plaques Easily detachable greasyscalesScalesDry or greasy masses of keratin that represent thickened stratum corneum.Secondary Skin Lesionsand yellow crusts ...
Typical postinfectious presentation In those patients whose acute glomerulonephritis is the result of a postinfectious cause (ie, poststreptococcal acute glomerulonephritis being the most common), a latent period of 7-21 days between onset of the streptococcal infection and development of clinical glomeru...
The development of new and effective antibacterial drugs to treat multi-drug resistant (MDR) bacteria, especially Gram-negative (G−ve) pathogens, is acknowledged as one of the world’s most pressing health issues; however, the discovery and developmen
The first approved pleuromutilin in 2007 was retapamulin, which is a topical treatment for impetigo [97, 98]. Antibiotics in the clinical pipeline in October 2019 Fig. 5 Structures of compounds in phase-III clinical trials 337 Like other pleuromutilins, lefamulin (9) inhibits bacterial protein ...
The characteristics of the identified cases, their clinical manifestations and the laboratory features at presentation were compared with those of matched ... Hsieh,Tauyee,Samson,... - 《Cmaj Canadian Medical Association Journal》 被引量: 37发表: 2000年 Streptococcus pyogenes: Basic Biology to Clin...
for treatment of vaccine complications with severe clinical manifestations (e.g., eczema vaccinatum, progressive vaccinia, severe generalized vaccinia, and severe ocular viral implantation) or vaccine infections in persons with skin disease (e.g., burns, eczema, impetigo, varicella-zoster)Footnote1*...